TFO
FATE icon

Tarbox Family Office’s Fate Therapeutics FATE Stock Holding History

Tarbox Family Office’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44
Closed -$2K – 418
2022
Q1 		$2K Hold
44
– – ﹤0.01% 799
2021
Q4 		$3K Hold
44
– – ﹤0.01% 773
2021
Q3 		$3K Hold
44
– – ﹤0.01% 784
2021
Q2 		$4K Hold
44
– – ﹤0.01% 708
2021
Q1 		$4K Hold
44
– – ﹤0.01% 631
2020
Q4 		$4K Hold
44
– – ﹤0.01% 584
2020
Q3 		$2K Hold
44
– – ﹤0.01% 761
2020
Q2 		$2K Hold
44
– – ﹤0.01% 749
2020
Q1 		$1K Buy
+44
New +$1.11K ﹤0.01% 850

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Tarbox Family Office's FATE Position: Q2 2022 in Review

Tarbox Family Office sold out of Fate Therapeutics (FATE) in Q2 2022, closing a stake of 44 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in FATE in Q1 2020 and held it in 9 quarters. The position peaked at $4K in Q2 2021. 233 funds tracked by Wall St. Rank hold FATE as of Q2 2022.

  • Tarbox Family Office reported no remaining Fate Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 44 Fate Therapeutics shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in Fate Therapeutics in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Fate Therapeutics position peaked at $4K in Q2 2021.
  • 233 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.